Cover Image

Anti-CD123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia

A novel niosomal delivery system was designed and investigated for the targeted delivery of daunorubicin (DNR) against acute myeloid leukemia (AML). Anti-CD123 antibodies conjugated to Mal-PEG2000-DSPE were incorporated into normal niosomes (NS) via a post insertion method to afford antibody-modifie...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fu-rong Liu (Author), Hui Jin (Author), Yin Wang (Author), Chen Chen (Author), Ming Li (Author), Sheng-jun Mao (Author), Qiantao Wang (Author), Hui Li (Author)
Format:	Book
Published:	Taylor & Francis Group, 2017-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

First‐in‐human study of JNJ‐63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia
by: Michael Boyiadzis, et al.
Published: (2023)

Evaluation of the CD123 Expression and FLT3 Gene Mutations in Patients with Acute Myeloid Leukemia
by: Freidoon Solhjoo, et al.
Published: (2018)

ABT-737, Synergistically Enhances Daunorubicin-Mediated Apoptosis in Acute Myeloid Leukemia Cell Lines
by: Hassan Dariushnejad, et al.
Published: (2014)

Novel CD123-aptamer-originated targeted drug trains for selectively delivering cytotoxic agent to tumor cells in acute myeloid leukemia theranostics
by: Haibin Wu, et al.
Published: (2017)

SPAG6 overexpression decreases the pro-apoptotic effect of daunorubicin in acute myeloid leukemia cells through the ROS/JNK MAPK axis in a GSTP1-dependent manner
by: Jie Luo, et al.
Published: (2024)

Randomized phase III trial comparing Daunorubicin and ara-C (DA) versus ara-C, Daunorubicin, and Etoposide (ADE) as induction chemotherapy in pediatric acute myeloid leukemia (InPOG-AML-16-01)
by: Venkatraman Radhakrishnan, et al.
Published: (2022)

Targeting the alpha subunit of IL-3 receptor (CD123) in patients with acute leukemia
by: Ibrahim Aldoss, et al.
Published: (2020)

First‐in‐human study of JNJ‐67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome
by: Rupa Narayan, et al.
Published: (2024)

Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles
by: Zhu Y, et al.
Published: (2023)

Novel CD123 polyaptamer hydrogel edited by Cas9/sgRNA for AML-targeted therapy
by: Haibin Wu, et al.
Published: (2021)

Casein-Based Nanoparticles: A Potential Tool for the Delivery of Daunorubicin in Acute Lymphocytic Leukemia
by: Nikolay Zahariev, et al.
Published: (2023)

Diagnostic Challenges of CD4+/CD56+/CD123+ hematological neoplasms
by: Leandro S. Thiago, et al.
Published: (2013)

Expression of CD71 by flow cytometry in acute leukemias: More often seen in acute myeloid leukemia
by: Amit Pande, et al.
Published: (2016)

Clinical and pathological features of myeloid leukemia cutis
by: Li Li, et al.
Published: (2018)

Myeloid Leukemia
Published: (2018)

Chidamide-based 3-drug combination regimen reverses molecular relapse post transplantation in AML1-ETO-positive acute myeloid leukemia
by: Yang Xi, et al.
Published: (2023)

Molecular landscape and targeted therapy of acute myeloid leukemia
by: Runxia Gu, et al.
Published: (2018)

Troponin-I and left ventricular function in pediatric high-risk acute lymphoblastic leukemia after daunorubicin treatment
by: Rinche Annur, et al.
Published: (2021)

Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial
by: Guillaume Drevin, et al.
Published: (2022)

Coexistence of T-cell lymphoblastic lymphoma and acute myeloid leukemia mimicking acute lymphocytic leukemia
by: Keyu Liu, et al.
Published: (2018)

The role of dasatinib in the management of chronic myeloid leukemia
by: Chen R, et al.
Published: (2015)

Gemtuzumab ozogamicin and novel antibody-drug conjugates in clinical trials for acute myeloid leukemia
by: Bo Yu, et al.
Published: (2019)

A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges
by: Ying Chen, et al.
Published: (2023)

Myeloid Leukemia Clinical Diagnosis and Treatment
Published: (2012)

Myeloid Leukemia Basic Mechanisms of Leukemogenesis
Published: (2011)

Advances in the drug therapies of acute myeloid leukemia (except acute promyelocytic leukemia)
by: Lin M, et al.
Published: (2018)

Cutaneous myeloid sarcoma associated with chronic myeloid leukemia
by: Erica Rodrigues de Araujo Vasconcelos, et al.
Published: (2017)

Pediatric chronic myeloid leukemia in myeloid blast crisis
by: Biswajit Dey, et al.
Published: (2023)

Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation
by: Bao W, et al.
Published: (2019)

A Novel CD48-Based Analysis of Sepsis-Induced Mouse Myeloid-Derived Suppressor Cell Compartments
by: Bei Jia, et al.
Published: (2017)

A newly modified HPLC method for estimation of dutasteride in prepared niosomes
by: Nidhal K. Maraie, et al.
Published: (2018)

Novel targeted therapies in chronic myeloid leukemia
by: Muhammad Sameer Ashaq, et al.
Published: (2024)

Loss of FGFR3 Delays Acute Myeloid Leukemogenesis by Programming Weakly Pathogenic CD117-Positive Leukemia Stem-Like Cells
by: Chen Guo, et al.
Published: (2021)

Immunotherapies for Acute Myeloid Leukemia
Published: (2020)

Targeting Approaches of Nanomedicines in Acute Myeloid Leukemia
by: Xiao Huang, et al.
Published: (2019)

Myeloid sarcoma on the scalp of a patient with acute myeloid leukemia
by: Débora Nogueira Muniz, et al.
Published: (2019)

Advances in targeted therapy for acute myeloid leukemia
by: Jifeng Yu, et al.
Published: (2020)

Carvedilol Attenuates Inflammatory-Mediated Cardiotoxicity in Daunorubicin-Induced Rats
by: Punniyakoti T. Veeravedu, et al.
Published: (2011)

Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26+ leukemia stem cells
by: Paola Pacelli, et al.
Published: (2023)

Safety and efficacy of a modified busulfan/cyclophosphamide conditioning regimen incorporating cladribine for autologous hematopoietic stem cell transplantation in acute myeloid leukemia
by: Yuan-Yuan Shi, et al.
Published: (2023)